Advanced search
Publication Cover
Cancer Management and Research Volume 13, 2021 - Issue
Submit an article Journal homepage
73
Views
4
CrossRef citations to date
0
Altmetric
Original Research

MiR-129-5p Suppresses Cell Proliferation of Human Osteosarcoma Cancer by Down-Regulating LncRNA Lnc712

Yifan YuDepartment of Orthopaedics, The Affiliated Huaian No.1 People’s Hospital of Nanjing Medical University, Huai’an City, Nanjing Province, 223300, People’s Republic of China
,
Wenshan ZuoDepartment of Orthopaedics, The Affiliated Huaian No.1 People’s Hospital of Nanjing Medical University, Huai’an City, Nanjing Province, 223300, People’s Republic of ChinaCorrespondence[email protected]
,
Wei CaiDepartment of Orthopaedics, The Affiliated Huaian No.1 People’s Hospital of Nanjing Medical University, Huai’an City, Nanjing Province, 223300, People’s Republic of China
,
Yong XuDepartment of Orthopaedics, The Affiliated Huaian No.1 People’s Hospital of Nanjing Medical University, Huai’an City, Nanjing Province, 223300, People’s Republic of China
,
Weidong LiuDepartment of Orthopaedics, The Affiliated Huaian No.1 People’s Hospital of Nanjing Medical University, Huai’an City, Nanjing Province, 223300, People’s Republic of China
&
Zexue ZhaoDepartment of Orthopaedics, The Affiliated Huaian No.1 People’s Hospital of Nanjing Medical University, Huai’an City, Nanjing Province, 223300, People’s Republic of China
Pages 2259-2264 | Published online: 10 Mar 2021

References

  • Klein MJ, Siegal GP. Osteosarcoma: anatomic and histologic variants. Am J Clin Pathol. 2006;125(4):555–581. doi:10.1309/UC6KQHLD9LV2KENN16627266
  • Durfee RA, Mohammed M, Luu HH. Review of osteosarcoma and current management. Rheumatol Ther. 2016;3(2):221–243. doi:10.1007/s40744-016-0046-y27761754
  • Anderson ME. Update on survival in osteosarcoma. Orthop Clin North Am. 2016;47(1):283–292. doi:10.1016/j.ocl.2015.08.02226614941
  • Kovar H. Selective enhancer changes in osteosarcoma lung metastasis. Nat Med. 2018;24(2):126–127. doi:10.1038/nm.448729414935
  • Meazza C, Scanagatta P. Metastatic osteosarcoma: a challenging multidisciplinary treatment. Expert Rev Anticancer Ther. 2016;16(5):543–556. doi:10.1586/14737140.2016.116869726999418
  • Song K, Song J, Lin K, et al. Survival analysis of patients with metastatic osteosarcoma: a surveillance, epidemiology, and end results population-based study. Int Orthop. 2019;43(8):1983–1991. doi:10.1007/s00264-019-04348-431127366
  • Kushlinskii NE, Fridman MV, Braga EA. Molecular mechanisms and microRNAs in osteosarcoma pathogenesis. Biochem (Mosc). 2016;81(4):315–328. doi:10.1134/S0006297916040027
  • Lin YH, Jewell BE, Gingold J, et al. Osteosarcoma: molecular pathogenesis and iPSC modeling. Trends Mol Med. 2017;23(8):737–755. doi:10.1016/j.molmed.2017.06.00428735817
  • Denduluri SK, Wang Z, Yan Z, et al. Molecular pathogenesis and therapeutic strategies of human osteosarcoma. J Biomed Res. 2015;30:30. doi:10.7555/JBR.29.20150075
  • Sayles LC, Breese MR, Koehne AL, et al. Genome-informed targeted therapy for osteosarcoma. Cancer Discov. 2019;9(1):46–63. doi:10.1158/2159-8290.CD-17-115230266815
  • Reddy KB. MicroRNA (miRNA) in cancer. Cancer Cell Int. 2015;15(1):38. doi:10.1186/s12935-015-0185-125960691
  • Liz J, Esteller M. lncRNAs and microRNAs with a role in cancer development. Biochim Biophys Acta. 2016;1859(1):169–176. doi:10.1016/j.bbagrm.2015.06.01526149773
  • Chen R, Wang G, Zheng Y, et al. Long non-coding RNAs in osteosarcoma. Oncotarget. 2017;8(12):20462–20475. doi:10.18632/oncotarget.1472628103585
  • Han C, Wang W. MicroRNA-129-5p suppresses cell proliferation, migration and invasion via targeting ROCK1 in osteosarcoma. Mol Med Rep. 2018;17(3):4777–4784. doi:10.3892/mmr.2018.837429328417
  • Cui Y, Lu C, Zhang Z, et al. A long non-coding RNA Lnc712 regulates breast cancer cell proliferation. Int J Biol Sci. 2020;16(1):162–171. doi:10.7150/ijbs.3642931892853
  • Cui D, Ni C. LncRNA Lnc712 promotes tumorigenesis in hepatocellular carcinoma by targeting miR-142-3p/Bach-1 axis. Cancer Manag Res. 2020;12:11285. doi:10.2147/CMAR.S25495033177878
  • Ma L, Chen X, Li C, et al. miR-129-5p and-3p co-target WWP1 to suppress gastric cancer proliferation and migration. J Cell Biochem. 2019;120(5):7527–7538. doi:10.1002/jcb.28027
  • Long XH, Zhou YF, Peng AF, et al. Demethylation-mediated miR-129-5p up-regulation inhibits malignant phenotype of osteogenic osteosarcoma by targeting homo sapiens valosin-containing protein (VCP). Tumour Biol. 2015;36(5):3799–3806. doi:10.1007/s13277-014-3021-725566966
  • Zhang R, Tang T, Yu HM, et al. LncRNA DLX6-AS1/miR-129-5p/DLK1 axis aggravates stemness of osteosarcoma through Wnt signaling. Biochem Biophys Res Commun. 2018;507(1–4):260–266. doi:10.1016/j.bbrc.2018.11.01930442366

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.